Together for Better Liver Health: Amplifying Best Practices Globally

On May 27, Global Liver Institute (GLI), in partnership with the European Association for the Study of the Liver (EASL), convened numerous esteemed key opinion leaders for a policy event on the sidelines of the 77th World Health Assembly in Geneva, Switzerland.

During the event, GLI unveiled their report, “Best Practices in Liver Health Policy: A Liver Health is Public Health Report,” which evaluates successful liver health policies from different countries as well as offer valuable insights to promote global strategies, addresses ongoing challenges faced by patients worldwide, and presents comprehensive policies to tackle these issues.

After the presentation of the report, the event continued with two high-level panels, moderated by Jeff McIntyre, MA, Vice President, Liver Health Programs at Global Liver Institute, in which a state representative (Egypt) and specialists from different areas of expertise converged on underlining the importance of having a holistic approach towards liver disease.

Comorbidities such as type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, or cardiometabolic risk factors frequently coexist with steatotic liver disease, commonly known as fatty liver disease. Shared risk factors contribute to the simultaneous occurrence of these conditions, amplifying their individual risks and compromising treatment outcomes. 

Patients who live with these conditions should be checked, as early as possible using non-invasive methods (e.g., liver ultrasound, fibroscan, or serum biomarkers). Early detection allows for targeted interventions. Regular screening, lifestyle modifications (weight management, dietary changes, and exercise), and judicious use of medications are essential. 

Watch the recap video below:

Panel 2: Centering Liver Health Perspectives from Different Key Stakeholders

Speakers from left to right:

Kremlin Wickramasinghe, PhD
Regional Adviser for Nutrition, Physical Activity and Obesity,
World Health Organization Regional Office for Europe

Sven Francque, MD, PhD
Hepatologist and Educational Councillor,
European Association for the Study of the Liver

Milan Mishkovikj, LLM
Director, European Liver Patients Association

Catherine Duggan, PhD
CEO, International Pharmaceutical Federation

Learn more about the program by checking our agenda here.